Food Detective can be used by healthcare practitioners to test for sensitivities across 59 common foods within the clinic setting.

For professional use only.

The Quantum Blue® rapid test combines the ease and speed of lateral flow technology (using a highly specific monoclonal antibody), with full quantification by means of a small, telephone sized reading device. The Quantum Blue® 3rd generation reader analyzes line intensities by state of the art image analysis and translates them into a quantitative result within minutes and is ideal to obtain test results fast and speed up the clinical decision. Besides calprotectin, BÜHLMANN offers the possibility for therapeutic drug monitoring (TDM) on the Quantum Blue® reader.

If you are looking for information on our older 2nd generation of the Quantum Blue® Reader, please visit this page.

The inflammation typical in Ulcerative Colitis and Crohn’s Disease is not present in IBS. It is thought that IBS affects over 30 million people in Europe and results in over 2 million visits annually to physicians. Fecal calprotectin is the ideal tool to differentiate IBS from IBD and to avoid unnecessary invasive diagnostic procedures.

The clinical course of most patients with IBD is marked by periods of remission with intermittent relapses characterized by increased intestinal inflammation. Numerous published studies by Tibble et al. and others, have studied the levels of calprotectin in patients during the course of the disease. The results show that calprotectin is a good predictor of relapse in patients with IBD, thus giving clinicians an effective tool to adapt the patients treatment accordingly and to ease the relapse severity.

Click here for more information on the Quantum Blue® calprotectin products.

Quantum Blue® – Therapeutic Drug Monitoring

BÜHLMANN has launched the first rapid test for therapeutic drug monitoring (TDM) in the market. The Quantum Blue® Adalimumab and the Quantum Blue® Infliximab assays offer trough level quantification of serum drug levels within 15 minutes. The tests use highly specific monoclonal antibodies and show a very high correlation to common ELISA assays.The Quantum Blue® Infliximab assay now also allows the detection of anti-drug antibodies (ADA) against Infliximab.

Click here for more information on the Quantum Blue® TDM portfolio

The QuikRead go Instrument is a compact, fully automatic instrument which is used for quantitative and qualitative measurements together with QuikRead go reagent kits. The QuikRead go system – consisting of the instrument and ready-to-use kits – is specially designed for use in primary healthcare settings. The instrument can be connected to HIS/LIS systems.

Generally

Traceability of test results ensures high quality and reliability. The instrument’s user interface enables a variety of settings to be personalised. There is a choice of 23 different languages, it is easy to add patient and/or operator identification information and the instrument can be easily combined with accessories, such as a barcode reader and a printer.

Ease of use combined with rapid results and reliability makes the QuikRead go system a valuable everyday diagnostic tool for healthcare professionals.

QuikRead go Instrument provides you with

Ease of use

  • Intuitive user interface
  • Interactive touch screen which guides users using animations

Minimal hands-on time

  • Automatic mixing and reagent addition in prefilled cuvettes
  • Results are automatically stored in the instrument’s internal memory, user and/or patient ID can be linked to the results

Connectivity

  • Three standard USB ports enable the use of memory sticks, a printer and a barcode reader
  • LIS/HIS connectivity

This version of QuikRead go Instrument is not registered in the USA (link to the US product version: QuikRead go Instrument for the USA).

Parallel testing in minutes

 

Get test results in just minutes to make faster, better-informed decisions. There’s absolutely no warm up time and you can run 6 independent tests simultaneously, critical when you don’t have time to waste. Its modular design also allows you to add more systems for even more throughout.

The RAMP Reader re-defines “reliable” taking acute care diagnostic testing out of the lab and into the ER, patient’s bedside or wherever testing is needed. It’s lightweight and can perform up to 100 tests on a single charge. Self-calibrating so that you don’t waste time, just turn it on and you’re ready to test.